Elon's Vision
  • Contacts
  • Privacy Policy
  • Terms & Conditions
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Elon's Vision
No Result
View All Result
Home Editor's Pick

Is Tort Reform the Way to Constrain Healthcare Costs?

by
October 13, 2023
in Editor's Pick
0
Is Tort Reform the Way to Constrain Healthcare Costs?
0
SHARES
17
VIEWS
Share on FacebookShare on Twitter

Jeffrey Miron

This article appeared on Substack on October 13, 2023.

The Wall Street Journal recently praised Nikki Haley for advocating healthcare tort reform during the Republican debate. Haley and the WSJ believe that excessive malpractice lawsuits increase healthcare costs by forcing doctors to pay for expensive insurance and by incentivizing unnecessary defensive procedures.

Healthcare costs are undoubtedly out of control. Yet the percentage of healthcare costs due to malpractice suits is modest and has been relatively stable over time.

Even if lawsuits were a major source of health cost inflation, tort law reform invites unintended consequences. Doctors may increase risky surgeries, for example, if they have less fear of being sued. Studies suggest that reforms have contributed to worse patient outcomes or increased use of certain procedures, implying higher costs.

The policies that cause high and rising health care costs are subsidies for health insurance (Medicare, Medicaid, Obamacare, and the tax exclusion for employer‐​paid health insurance premiums). Politicians looking to constrain health costs should trim these subsidies.

Previous Post

Massimo Acquaviva: What is Due Diligence?

Next Post

Reforming Medicaid Subsidies

Next Post
Reforming Medicaid Subsidies

Reforming Medicaid Subsidies

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest

Jay Bhattacharya on Public Health

October 12, 2021

That Bangladesh Mask Study!

December 1, 2021

Antitrust Regulation Assumes Bureaucrats Know the “Correct” Amount of Competition

November 24, 2021
Pints of champagne could be the next ‘Brexit dividend’

Pints of champagne could be the next ‘Brexit dividend’

December 24, 2021

Data Analysis Identifies Xpertnest as One of UK’s Top 500 Rapidly Expanding Businesses

0

0

0

0

Data Analysis Identifies Xpertnest as One of UK’s Top 500 Rapidly Expanding Businesses

July 8, 2025
UK Government unveils £92bn transport overhaul to drive growth and connect communities

UK Government unveils £92bn transport overhaul to drive growth and connect communities

July 8, 2025

TNA Investigation Finds UK Supported French Police Tactics Resulted in Migrant Drowning

July 8, 2025
Trump’s tariffs send UK borrowing costs soaring, forcing Reeves to rethink economic roadmap

Trump’s tariffs send UK borrowing costs soaring, forcing Reeves to rethink economic roadmap

July 8, 2025

Recent News

Data Analysis Identifies Xpertnest as One of UK’s Top 500 Rapidly Expanding Businesses

July 8, 2025
UK Government unveils £92bn transport overhaul to drive growth and connect communities

UK Government unveils £92bn transport overhaul to drive growth and connect communities

July 8, 2025

TNA Investigation Finds UK Supported French Police Tactics Resulted in Migrant Drowning

July 8, 2025
Trump’s tariffs send UK borrowing costs soaring, forcing Reeves to rethink economic roadmap

Trump’s tariffs send UK borrowing costs soaring, forcing Reeves to rethink economic roadmap

July 8, 2025

Disclaimer: ElonsVision.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • Contacts
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 ElonsVision. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 ElonsVision. All Rights Reserved.